These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 16898186
1. Atherogenic oxidized low-density lipoprotein/beta2-glycoprotein I (oxLDL/beta2GPI) complexes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Matsuura E, Kobayashi K, Hurley BL, Lopez LR. Lupus; 2006; 15(7):478-83. PubMed ID: 16898186 [Abstract] [Full Text] [Related]
2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR, Simpson DF, Hurley BL, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [Abstract] [Full Text] [Related]
3. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lopez LR, Salazar-Paramo M, Palafox-Sanchez C, Hurley BL, Matsuura E, Garcia-De La Torre I. Lupus; 2006 Jun; 15(2):80-6. PubMed ID: 16539278 [Abstract] [Full Text] [Related]
6. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D, Garcia-Valladares I, Palafox-Sanchez CA, De La Torre IG, Kobayashi K, Matsuura E, Lopez LR. Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048 [Abstract] [Full Text] [Related]
7. Immunogenic oxidized low-density lipoprotein/beta2-glycoprotein I complexes in the diagnostic management of atherosclerosis. Lopez LR, Kobayashi K, Matsunami Y, Matsuura E. Clin Rev Allergy Immunol; 2009 Aug; 37(1):12-9. PubMed ID: 18982458 [Abstract] [Full Text] [Related]
8. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome. Kobayashi K, Lopez LR, Matsuura E. Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014 [Abstract] [Full Text] [Related]
9. The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis. Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E. Ann N Y Acad Sci; 2005 Jun; 1051():442-54. PubMed ID: 16126986 [Abstract] [Full Text] [Related]
10. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR. Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279 [Abstract] [Full Text] [Related]
11. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Matsuura E, Kobayashi K, Inoue K, Lopez LR, Shoenfeld Y. Lupus; 2005 Nov; 14(9):736-41. PubMed ID: 16218478 [Abstract] [Full Text] [Related]
13. IgG autoantibodies against beta2-glycoprotein I complexed with a lipid ligand derived from oxidized low-density lipoprotein are associated with arterial thrombosis in antiphospholipid syndrome. Lopez D, Kobayashi K, Merrill JT, Matsuura E, Lopez LR. Clin Dev Immunol; 2003 Nov; 10(2-4):203-11. PubMed ID: 14768953 [Abstract] [Full Text] [Related]
16. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Romero FI, Amengual O, Atsumi T, Khamashta MA, Tinahones FJ, Hughes GR. Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680 [Abstract] [Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA. Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [Abstract] [Full Text] [Related]